More than 100,000 people in Australia live with Parkinson’s—a central nervous system disorder affecting one’s movement and mood. It is…
For patients given less than five years to live after being diagnosed with myelofibrosis, there is a new flicker of…
Aptar Pharma has deemed now the perfect time to exercise their option to purchase an inventive piece of Pharmaxis’ (ASX:…
The skin is one of the most overlooked, complex and essential organs. It is the body’s first line of defence…